Randomized trial finds CBD did not reduce severe behavioral problems
Cannabidiol for Severe Behavioral Problems in Youths With Intellectual Disability: A Randomized Clinical Trial.
AI Summary
This randomized, double-blind, placebo-controlled clinical trial tested whether CBD could reduce severe behavioral problems in 131 children and adolescents aged 6 to 18 years with intellectual disability. Participants received CBD or placebo for 8 weeks, followed by a 4-week follow-up. The primary outcome was parent-reported irritability on the Aberrant Behavior Checklist.
At the end of treatment, irritability scores were similar in the CBD and placebo groups, and the trial concluded that CBD was not effective for these behavioral problems in this population. At least one adverse event was reported by a similar proportion of participants in each group. This is an abstract-based summary; the abstract does not establish effects in other populations, for other uses of CBD, or beyond the study period.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More CBD research papers you might find interesting.
Preclinical evidence finds no stable CBD dose-response for fear
Post hoc TSC analysis links caregiver-perceived improvement to seizure…
Repeated high-dose CBD in young rats was followed by mixed social changes and…
Explore More Research
Stay informed about the latest cannabis science.